Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.

Edwards SJ, Hamilton V, Nherera L, Trevor N.

Health Technol Assess. 2013 Nov;17(54):1-190. doi: 10.3310/hta17540. Review.

PMID:
24284258
[PubMed - indexed for MEDLINE]
Free Article
2.

The cost-effectiveness of group cognitive behavioral therapy compared with routine primary care for women with postnatal depression in the UK.

Stevenson MD, Scope A, Sutcliffe PA.

Value Health. 2010 Aug;13(5):580-4. doi: 10.1111/j.1524-4733.2010.00720.x. Epub 2010 Mar 31.

PMID:
20384978
[PubMed - indexed for MEDLINE]
3.

Cost-effectiveness of a stepped care intervention to prevent depression and anxiety in late life: randomised trial.

Van't Veer-Tazelaar P, Smit F, van Hout H, van Oppen P, van der Horst H, Beekman A, van Marwijk H.

Br J Psychiatry. 2010 Apr;196(4):319-25. doi: 10.1192/bjp.bp.109.069617.

PMID:
20357310
[PubMed - indexed for MEDLINE]
Free Article
4.

Economic evaluation of online computerised cognitive-behavioural therapy without support for depression in primary care: randomised trial.

Gerhards SA, de Graaf LE, Jacobs LE, Severens JL, Huibers MJ, Arntz A, Riper H, Widdershoven G, Metsemakers JF, Evers SM.

Br J Psychiatry. 2010 Apr;196(4):310-8. doi: 10.1192/bjp.bp.109.065748.

PMID:
20357309
[PubMed - indexed for MEDLINE]
Free Article
5.

Cost-effectiveness of collaborative care for the treatment of major depressive disorder in primary care. A systematic review.

van Steenbergen-Weijenburg KM, van der Feltz-Cornelis CM, Horn EK, van Marwijk HW, Beekman AT, Rutten FF, Hakkaart-van Roijen L.

BMC Health Serv Res. 2010 Jan 19;10:19. doi: 10.1186/1472-6963-10-19. Review.

PMID:
20082727
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Screening for postnatal depression in primary care: cost effectiveness analysis.

Paulden M, Palmer S, Hewitt C, Gilbody S.

BMJ. 2009 Dec 22;339:b5203. doi: 10.1136/bmj.b5203. Review.

PMID:
20028779
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Diagnostic validity and added value of the Geriatric Depression Scale for depression in primary care: a meta-analysis of GDS30 and GDS15.

Mitchell AJ, Bird V, Rizzo M, Meader N.

J Affect Disord. 2010 Sep;125(1-3):10-7. doi: 10.1016/j.jad.2009.08.019. Epub 2009 Oct 2.

PMID:
19800132
[PubMed - indexed for MEDLINE]
8.

Cost-effectiveness of a minimal intervention for stress-related sick leave in general practice: results of an economic evaluation alongside a pragmatic randomised control trial.

Uegaki K, Bakker I, de Bruijne M, van der Beek A, Terluin B, van Marwijk H, Heymans M, Stalman W, van Mechelen W.

J Affect Disord. 2010 Jan;120(1-3):177-87. doi: 10.1016/j.jad.2009.04.012. Epub .

PMID:
19439362
[PubMed - indexed for MEDLINE]
9.

Exploring the Postpartum Adjustment Questionnaire as a predictor of postpartum depression.

Davis S, Cross J, Lind BK.

J Obstet Gynecol Neonatal Nurs. 2008 Nov-Dec;37(6):622-30. doi: 10.1111/j.1552-6909.2008.00286.x.

PMID:
19012712
[PubMed - indexed for MEDLINE]
10.

A budget-impact and cost-effectiveness model for second-line treatment of major depression.

Malone DC.

J Manag Care Pharm. 2007 Jul;13(6 Suppl A):S8-18.

PMID:
17874482
[PubMed - indexed for MEDLINE]
Free Article
11.

A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care.

Sørensen J, Stage KB, Damsbo N, Le Lay A, Hemels ME.

Nord J Psychiatry. 2007;61(2):100-8.

PMID:
17454724
[PubMed - indexed for MEDLINE]
12.

The costs and benefits of enhanced depression care to employers.

Wang PS, Patrick A, Avorn J, Azocar F, Ludman E, McCulloch J, Simon G, Kessler R.

Arch Gen Psychiatry. 2006 Dec;63(12):1345-53.

PMID:
17146009
[PubMed - indexed for MEDLINE]
13.

Cost-effectiveness of preventing depression in primary care patients: randomised trial.

Smit F, Willemse G, Koopmanschap M, Onrust S, Cuijpers P, Beekman A.

Br J Psychiatry. 2006 Apr;188:330-6.

PMID:
16582059
[PubMed - indexed for MEDLINE]
Free Article
14.

Implications of an SSRI generic step therapy pharmacy benefit design: an economic model in anxiety disorders.

Panzer PE, Regan TS, Chiao E, Sarnes MW.

Am J Manag Care. 2005 Oct;11(12 Suppl):S370-9.

PMID:
16236019
[PubMed - indexed for MEDLINE]
Free Article
15.

One size fits some: the impact of patient treatment attitudes on the cost-effectiveness of a depression primary-care intervention.

Pyne JM, Rost KM, Farahati F, Tripathi SP, Smith J, Williams DK, Fortney J, Coyne JC.

Psychol Med. 2005 Jun;35(6):839-54.

PMID:
15997604
[PubMed - indexed for MEDLINE]
16.
17.

A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium.

Demyttenaere K, Hemels ME, Hudry J, Annemans L.

Clin Ther. 2005 Jan;27(1):111-24.

PMID:
15763612
[PubMed - indexed for MEDLINE]
18.

Disease management programs for depression: a systematic review and meta-analysis of randomized controlled trials.

Neumeyer-Gromen A, Lampert T, Stark K, Kallischnigg G.

Med Care. 2004 Dec;42(12):1211-21. Review.

PMID:
15550801
[PubMed - indexed for MEDLINE]
19.

Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria.

Hemels ME, Kasper S, Walter E, Einarson TR.

Curr Med Res Opin. 2004 Jun;20(6):869-78.

PMID:
15200745
[PubMed - indexed for MEDLINE]
20.

Cost-effectiveness of escitalopram versus citalopram in the treatment of severe depression.

Hemels ME, Kasper S, Walter E, Einarson TR.

Ann Pharmacother. 2004 Jun;38(6):954-60. Epub 2004 Apr 27. Erratum in: Ann Pharmacother. 2004 Sep;38(9):1545.

PMID:
15113989
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk